140 related articles for article (PubMed ID: 8510754)
21. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
22. Activation of complement by an IgG molecule without a genetic hinge.
Brekke OH; Michaelsen TE; Sandlin R; Sandlie I
Nature; 1996 Sep; 383(6595):103. PubMed ID: 8779724
[No Abstract] [Full Text] [Related]
23. Flexibility of human IgG subclasses.
Roux KH; Strelets L; Michaelsen TE
J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
[TBL] [Abstract][Full Text] [Related]
24. Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.
Newman R; Hariharan K; Reff M; Anderson DR; Braslawsky G; Santoro D; Hanna N; Bugelski PJ; Brigham-Burke M; Crysler C; Gagnon RC; Dal Monte P; Doyle ML; Hensley PC; Reddy MP; Sweet RW; Truneh A
Clin Immunol; 2001 Feb; 98(2):164-74. PubMed ID: 11161972
[TBL] [Abstract][Full Text] [Related]
25. Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes.
Attanasio R; Jayashankar L; Engleman CN; Scinicariello F
Immunogenetics; 2002 Nov; 54(8):556-61. PubMed ID: 12439618
[TBL] [Abstract][Full Text] [Related]
26. Intrachain disulfide bond in the core hinge region of human IgG4.
Bloom JW; Madanat MS; Marriott D; Wong T; Chan SY
Protein Sci; 1997 Feb; 6(2):407-15. PubMed ID: 9041643
[TBL] [Abstract][Full Text] [Related]
27. Effector functions of a mouse IgG that lacks the entire CH1 domain. C1q binding and complement fixation in the absence of antigen.
Mizutani R; Igarashi T; Tanaka T; Shimada I; Arata Y
J Immunol; 1993 Jan; 150(1):131-8. PubMed ID: 8417119
[TBL] [Abstract][Full Text] [Related]
28. Structural motifs involved in human IgG antibody effector functions.
Greenwood J; Clark M; Waldmann H
Eur J Immunol; 1993 May; 23(5):1098-104. PubMed ID: 8477804
[TBL] [Abstract][Full Text] [Related]
29. Aspects of the molecular structure of IgG subclasses.
Burton DR; Gregory L; Jefferis R
Monogr Allergy; 1986; 19():7-35. PubMed ID: 2945094
[No Abstract] [Full Text] [Related]
30. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
[TBL] [Abstract][Full Text] [Related]
31. Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis.
Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
Mol Immunol; 1993 Nov; 30(16):1419-25. PubMed ID: 8232327
[TBL] [Abstract][Full Text] [Related]
32. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
33. Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry.
Roux KH; Strelets L; Brekke OH; Sandlie I; Michaelsen TE
J Immunol; 1998 Oct; 161(8):4083-90. PubMed ID: 9780179
[TBL] [Abstract][Full Text] [Related]
34. Aspects of immunoglobulin G structure relevant to its interaction with Fc receptors.
Dorrington KJ; Klein M
Arch Immunol Ther Exp (Warsz); 1981; 29(3):275-82. PubMed ID: 6794538
[TBL] [Abstract][Full Text] [Related]
35. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
[TBL] [Abstract][Full Text] [Related]
36. Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
White DM; Jensen MA; Shi X; Qu Zx ; Arnason BG
Protein Expr Purif; 2001 Apr; 21(3):446-55. PubMed ID: 11281720
[TBL] [Abstract][Full Text] [Related]
37. Conjugation of human Fc gamma in closed-hinge or open-hinge configuration to Fab'gamma and analogous ligands.
Stevenson GT; Anderson VA; Kan KS; Worth AT
J Immunol; 1997 Mar; 158(5):2242-50. PubMed ID: 9036971
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the immunoglobulin A heavy chain gene of the Atlantic bottlenose dolphin (Tursiops truncatus).
Mancia A; Romano TA; Gefroh HA; Chapman RW; Middleton DL; Warr GW; Lundqvist ML
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):304-9. PubMed ID: 17572508
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
Imai M; Ohta R; Varela JC; Song H; Tomlinson S
Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
[TBL] [Abstract][Full Text] [Related]
40. In vitro characterization of five humanized OKT3 effector function variant antibodies.
Xu D; Alegre ML; Varga SS; Rothermel AL; Collins AM; Pulito VL; Hanna LS; Dolan KP; Parren PW; Bluestone JA; Jolliffe LK; Zivin RA
Cell Immunol; 2000 Feb; 200(1):16-26. PubMed ID: 10716879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
